Brian Hanley

Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.

Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada.

Upline Securities SA is the securities brokerage subsidiary of Upline Group, which id owned by Banque Centrale Populaire SA (CSE: BCP) in Morocco. Founded in 1993, the firm is headquartered in Casablanca and is a reference intervener in the Moroccan stock market. Upline Securities is positioned across a large local and international clientele, and ensures efficient execution of transactions.

RMA Capital is the wholly owned asset management subsidiary of RMA WATANYA SA, itself a subsidiary of Othman Benjelloun’s FinanceCom SA in Morocco. The firm was founded by Réda El Alj in 2008. Headquartered in Casablanca, RMA Capital exclusively manages the assets of their parent company, RMA.

Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom.

AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland.

Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada.

MRCL, Inc. provides research laboratory services. The private company is based in Montréal, Canada. The Canadian company was founded by Marc Rivière.

Festival Classica, Inc. conducts events and musical shows. The private company is based in Saint-Lambert, Canada.

Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Kimera Corp. provides investment advice. The private company is based in Dubai, United Arab Emirates.

ImmunoRx Pharma, Inc. manufactures pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Juan Felipe Velasquez.

GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada.

Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada.